Page last updated: 2024-09-22

muzolimine

Description

Muzolimine: A pyrazole diuretic with long duration and high capacity of action. It was proposed for kidney failure and hypertension but was withdrawn worldwide because of severe neurological effects. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID41386
CHEMBL ID1697760
CHEBI ID135124
SCHEMBL ID123392
MeSH IDM0014278

Synonyms (48)

Synonym
3-amino-1-(3,4-dichloro-alpha-methylbenzyl)-2-pyrazolin-5-one
5-amino-2-(1-(3,4-dichlorophenyl)-ethyl)-2,4-dihydro-3h-pyrazol-3-one
3-amino-1-(3,4-dichloro-alpha-methylbenzyl)-4,5-dihydro-5-pyrazolon
brn 0660881
muzolimina [inn-spanish]
einecs 259-573-2
bay g 2821
muzolimina [spanish]
3h-pyrazol-3-one, 2,4-dihydro-5-amino-2-(1-(3,4-dichlorophenyl)ethyl)-
edrul
3h-pyrazol-3-one, 5-amino-2-(1-(3,4-dichlorophenyl)ethyl)-2,4-dihydro-
muzoliminum [inn-latin]
muzolimine (usan/inn)
D05093
55294-15-0
bay-g-2821
muzolimine
CHEBI:135124
5-amino-2-[1-(3,4-dichlorophenyl)ethyl]-4h-pyrazol-3-one
CHEMBL1697760
bay-g 2821
muzoliminum
unii-07z36289zx
muzolimina
muzolimine [usan:inn:ban]
07z36289zx ,
SCHEMBL123392
muzolimine [usan]
muzolimine [mi]
muzolimine [who-dd]
3-amino-1-(3,4-dichloro-a-methylbenzyl)-2-pyrazolin-5-one
muzolimine [inn]
muzolimine [mart.]
RLWRMIYXDPXIEX-UHFFFAOYSA-N
3-amino-1-(1-(3,4-dichlorophenyl)ethyl)-1h-pyrazol-5(4h)-one
AKOS028110654
3h-pyrazol-3-one, 5-amino-2-[1-(3,4-dichlorophenyl)ethyl]-2,4-dihydro-
5-amino-2-[1-(3,4-dichlorophenyl)ethyl]-2,4-dihydro-3h-pyrazol-3-one
DTXSID50866476
Q3868794
FT-0759718
DB13801
bay-g 2821; edrul
3-amino-1-[1-(3,4-dichlorophenyl)ethyl]-4,5-dihydro-1h-pyrazol-5-one
EN300-18568082
CS-0026158
HY-106616
5-amino-2-(1-(3,4-dichlorophenyl)ethyl)-2,4-dihydro-3h-pyrazol-3-one

Research Excerpts

Overview

ExcerptReference
"Muzolimine is a loop diuretic with an original chemical structure devoid of the acidic or sulfonamide group known to be necessary for an interaction with Na+K+Cl- cotransport. "( Barthelmebs, M; Grima, M; Imbs, JL; Michel, B; Stephan, D, 1991)
"Muzolimine is a diuretic which has been proposed in the treatment of hypertension. "( Barthelmebs, M; Grima, M; Imbs, JL; Michel, B, 1990)
"Muzolimine is a new diuretic which acts on the ascending limb of the loop of Henle and on the distal tubule."( Fillastre, JP; Morin, JP; Olier, B; Toutain, H, 1987)
"Muzolimine appears to be an effective and safe antihypertensive agent."( Clementy, J; Wicker, P, 1986)
"Muzolimine is a diuretic with chemical features different from all other known diuretics, and its use seem to be particularly interesting in patients with chronic renal failure. "( Colla, L; Dogliani, M; Squiccimarro, G; Stratta, P; Vercellone, A, 1985)

Actions

ExcerptReference
"Muzolimine: 1) increase PRA (11.8 +/- 1.06 vs. "( Antonello, A; Bardini, R; Borsatti, A; Calò, L; Cantaro, S; Piccoli, A; Vianello, A, 1985)
"Muzolimine 20 mg did not increase mean 24 h urinary Na+ output significantly with respect to placebo."( Leary, WP; Reyes, AJ; van der Byl, K, 1985)

Treatment

ExcerptReference
"Muzolimine pretreatment of rats for 2 months did not influence the elastin content of arterial tissue or [3H]glycine incorporation into aortic elastin under organ culture conditions, but after labelling the elastin with [4,5-3H]lysine, the [3H]desmosine and [3H]-isodesmosine isolated from the elastin of muzolimine-pretreated rats and incorporated under organ culture conditions was lower than that of control animals."( Buddecke, E; Busse, WD; Garthoff, B; Gau, W; Ritter, W; Schmidt, A; Wünsche, C, 1984)
"Treatment with muzolimine by food (in a concentration of 800 ppm for four days) and additional oral gavage one hour prior to ischemia prevented the sequelae of ischemia to a great extent."( Garthoff, B, 1985)

Drug Classes (1)

ClassDescription
dichlorobenzeneAny member of the class of chlorobenzenes carrying two chloro groups at unspecified positions.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (86)

TimeframeStudies, This Drug (%)All Drugs %
pre-199075 (87.21)18.7374
1990's10 (11.63)18.2507
2000's0 (0.00)29.6817
2010's1 (1.16)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials25 (27.78%)5.53%
Reviews2 (2.22%)6.00%
Case Studies4 (4.44%)4.05%
Observational0 (0.00%)0.25%
Other59 (65.56%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research Highlights

Safety/Toxicity (2)

ArticleYear
[Can gentamicin nephrotoxicity in rats be modified by chronic administration of muzolimine?].
Pathologie-biologie, Volume: 34, Issue: 5 Pt 2
1986
Influence of muzolimine, a new diuretic, on experimental gentamicin nephrotoxicity.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Volume: 2, Issue: 6
1987
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Long-term Use (4)

ArticleYear
Acute and chronic diuretic-induced alterations in urinary sodium and calcium excretion in the conscious rat.
Mineral and electrolyte metabolism, Volume: 8, Issue: 6
1982
Muzolimine in the treatment of essential arterial hypertension not controlled with other antihypertensive drugs.
Zeitschrift fur Kardiologie, Volume: 74 Suppl 2
1985
Pharmacokinetics and pharmacodynamics of muzolimine in chronic heart failure.
Zeitschrift fur Kardiologie, Volume: 74 Suppl 2
1985
[Can gentamicin nephrotoxicity in rats be modified by chronic administration of muzolimine?].
Pathologie-biologie, Volume: 34, Issue: 5 Pt 2
1986
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pharmacokinetics (10)

ArticleYear
[Pharmacodynamic and pharmacokinetic studies of muzolimine in patients with hepatogeneous ascites (author's transl)].
Zeitschrift fur Gastroenterologie, Volume: 18, Issue: 10
1980
Pharmacokinetics and saluretic effect of muzolimine in severe cardiac failure.
Current medical research and opinion, Volume: 6, Issue: 6
1980
Clinical study of muzolimine in acute renal failure, pharmacodynamics and pharmacokinetics.
Zeitschrift fur Kardiologie, Volume: 74 Suppl 2
1985
Diuretic effect and pharmacokinetic data observed at different stages of chronic renal failure with 240 mg of muzolimine.
Zeitschrift fur Kardiologie, Volume: 74 Suppl 2
1985
Pharmacokinetics of muzolimine after acute and chronic dosing in hypertensive patients with mild renal insufficiency.
Zeitschrift fur Kardiologie, Volume: 74 Suppl 2
1985
Pharmacokinetics and pharmacodynamics of muzolimine in chronic heart failure.
Zeitschrift fur Kardiologie, Volume: 74 Suppl 2
1985
Pharmacokinetics of muzolimine after oral administration with and without aluminium hydroxide in healthy volunteers.
Zeitschrift fur Kardiologie, Volume: 74 Suppl 2
1985
Pharmacodynamic and pharmacokinetic correlation of muzolimine with and without aluminium hydroxide.
Zeitschrift fur Kardiologie, Volume: 74 Suppl 2
1985
Effects of haemodialysis on the pharmacokinetics of muzolimine.
Zeitschrift fur Kardiologie, Volume: 74 Suppl 2
1985
Is the antihypertensive effect of muzolimine due to volume depletion?
Zeitschrift fur Kardiologie, Volume: 74 Suppl 2
1985
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (1)

ArticleYear
Food and muzolimine interaction.
Zeitschrift fur Kardiologie, Volume: 74 Suppl 2
1985
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (11)

ArticleYear
Clinicopharmacological reappraisal of the potency of diuretics.
Cardiovascular drugs and therapy, Volume: 7 Suppl 1
1993
Pharmacokinetics of muzolimine after acute and chronic dosing in hypertensive patients with mild renal insufficiency.
Zeitschrift fur Kardiologie, Volume: 74 Suppl 2
1985
Pharmacokinetics and pharmacodynamics of muzolimine in chronic heart failure.
Zeitschrift fur Kardiologie, Volume: 74 Suppl 2
1985
Beneficial effect of muzolimine in postischemic acute renal failure in rats.
Zeitschrift fur Kardiologie, Volume: 74 Suppl 2
1985
Pharmacokinetics of muzolimine after oral administration with and without aluminium hydroxide in healthy volunteers.
Zeitschrift fur Kardiologie, Volume: 74 Suppl 2
1985
The effects of single doses of muzolimine upon urinary solute and fluid excretion.
Zeitschrift fur Kardiologie, Volume: 74 Suppl 2
1985
Step-dose of muzolimine at different stages of chronic renal failure: comparison with furosemide.
Zeitschrift fur Kardiologie, Volume: 74 Suppl 2
1985
[Can gentamicin nephrotoxicity in rats be modified by chronic administration of muzolimine?].
Pathologie-biologie, Volume: 34, Issue: 5 Pt 2
1986
Muzolimine and nitrendipine in the treatment of arterial hypertension.
Zeitschrift fur Kardiologie, Volume: 74 Suppl 2
1985
Muzolimine: renal site of action and interaction with probenecid in humans.
Clinical pharmacology and therapeutics, Volume: 50, Issue: 5 Pt 1
1991
Muzolimine-induced severe neuromyeloencephalopathy: report of seven cases.
Acta neurologica Scandinavica, Volume: 83, Issue: 1
1991
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]